Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Newly Diagnosed Multiple Myeloma (MM)
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2008-02-18
- Last Posted Date
- 2014-01-17
- Target Recruit Count
- 57
- Registration Number
- NCT00617591
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid
- Conditions
- Small Cell Lung Cancer
- Interventions
- Drug: All -trans Retinoic Acid (ATRA)
- First Posted Date
- 2008-02-18
- Last Posted Date
- 2019-11-08
- Target Recruit Count
- 69
- Registration Number
- NCT00617409
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States
The Specific Role of Isoflavones in Reducing Prostate Cancer Risk
- Conditions
- Prostate Cancer
- Interventions
- Other: PlaceboDietary Supplement: Prevastein HC®
- First Posted Date
- 2008-02-18
- Last Posted Date
- 2012-09-24
- Target Recruit Count
- 52
- Registration Number
- NCT00617617
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant Chem
- First Posted Date
- 2008-02-12
- Last Posted Date
- 2017-03-23
- Target Recruit Count
- 1
- Registration Number
- NCT00612677
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors
- Conditions
- Pancreatic Cancer
- Interventions
- First Posted Date
- 2008-02-07
- Last Posted Date
- 2017-03-23
- Target Recruit Count
- 1
- Registration Number
- NCT00609765
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Lenalidomide in Comb w/Rituximab for Pts w/CD5+/CD20+ Hem Malignancies Who Relapse/Progress After Rituximab
- Conditions
- Lymphocytic LeukemiaMantle Cell Lymphoma
- Interventions
- First Posted Date
- 2008-02-07
- Last Posted Date
- 2015-09-17
- Target Recruit Count
- 29
- Registration Number
- NCT00609869
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
🇺🇸Center for Cancer Care & Research/Watson, Lakeland, Florida, United States
A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma
- First Posted Date
- 2008-02-01
- Last Posted Date
- 2012-11-19
- Target Recruit Count
- 30
- Registration Number
- NCT00606008
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM)
- Conditions
- Mesothelioma
- Interventions
- Drug: Carboplatin, Bevacizumab and Pemetrexed
- First Posted Date
- 2008-01-30
- Last Posted Date
- 2017-03-23
- Target Recruit Count
- 13
- Registration Number
- NCT00604461
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States
Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer
- Conditions
- Lung Cancer
- Interventions
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2013-05-24
- Target Recruit Count
- 24
- Registration Number
- NCT00601796
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic Melanoma
- First Posted Date
- 2008-01-22
- Last Posted Date
- 2013-12-11
- Target Recruit Count
- 35
- Registration Number
- NCT00598507
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States